Celgene Corporation, a global biopharmaceutical company headquartered in Summit, New Jersey, has earned the prestigious global CEO Cancer Gold StandardTM accreditation. This accreditation recognizes the Company’s worldwide commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring broad access to innovative cancer therapies that are extending lives, improving quality of life and increasing productivity for employees and their family members around the globe.
This nonprofit organization of CEOs, founded by former President George H.W. Bush, created the Gold Standard in collaboration with the National Cancer Institute (NCI), many of its designated cancer centers, and other leading health organizations. The Gold Standard requires employers to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to reduce the risk of cancer in the workplace and support early diagnosis and quality treatment.
“This global Gold Standard certification acknowledges the personal leadership of Celgene Chairman and CEO Bob Hugin and recognizes that Celgene’s efforts to improve health begin with the company’s own employees and their family members,” said Christopher A. Viehbacher, Chairman of the CEO Roundtable on Cancer.
To be accredited as a global Gold Standard organization, employers must achieve and maintain CEO Cancer Gold Standard accreditation in the U.S., maintain a tobacco-free policy worldwide, and satisfy the essence and spirit of the five key areas of workplace wellness that are foundations of the Gold Standard; supporting tobacco cessation efforts and further encouraging prevention by promoting physical activity, healthy nutrition and weight management; detecting cancer at its earliest stages; and providing access to quality cancer treatment, including participation in clinical trials. Today, over four and a half million employees and family members are benefiting from the vision and leadership of 170 employers who have chosen to become Gold Standard accredited employers.
“The CEO Roundtable on Cancer plays a vitally important role in promoting healthy workplaces and supporting employers in their commitment to prevention, early diagnosis and access to quality treatment of cancer for their employees. We are proud to partner with the CEO Roundtable as a Global Gold Standard employer,” said Robert J. Hugin, Chairman and Chief Executive Officer of Celgene Corporation.
In addition to NCI and the Centers for Disease Control and Prevention, 16 NCI-designated cancer centers and more than 60 other hospitals have earned Gold Standard accreditation. CEOs from many industries are keenly aware of the critical impact on employee health and healthcare costs as well as productivity gains when they address cancer and other chronic diseases. Gold Standard employers include: Avis Budget Group, Harvard School of Public Health, Lowe’s, Aetna, State Farm, Hogan Lovells, Dell, Johnson & Johnson, Novartis, SAS and many Blue Cross affiliates.
About Celgene Corporation
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit www.celgene.com.